A recent Centers for Disease Control and Prevention report showed the challenges rural health care faces and the need for provider status legislation. Read More »
The 22nd PBMI Annual Drug Benefit Conference is set for March 6-8 in Orlando, Florida. Read More »
Members of the American Pharmacists Association submitted a joint statement to President Donald Trump's administration, asking for an appeal to a recent U.S. Food and Drug Administration decision saying a pharmacist cannot begin to fill a patient’s prescription without a written, valid prescription on hand. Read More »
The FDA has extended the review period for Baricitnib, a new once-a-day drug for rheumatoid arthritis. Read More »
Dealing with the thorny, and often contentious, issue of drug prices is likely to be front and center in the early days of the new Trump administration. Arriving at a solution to curb increasing costs will be a delicate balance for all those with a stake in the issue, according to a leading health economist. Read More »
New data from the Centers for Medicare and Medicaid Services shows that major chain pharmacies such as CVS, Walgreens and Walmart account for over 79 percent of Prescription Drug Plans for the elderly. Read More »
New legislation for Medicare Part B beneficiaries has recently been reintroduced to the Senate to give underserved communities access to pharmacist-provided care. Read More »
New data released by the Department of Health and Human Services shows that adults with disabilities on Medicare continue to save on prescriptions, and that there has been an increase in benefits from last year as a result of the Affordable Care Act. Read More »
The U.S. Food and Drug Administration has approved Vantrelatm, a pain medication designed by Teva Pharmaceutical Ltd., for long-term use in time-released capsules. Read More »
Following recent public reaction to the price of epinephrine auto-injector pens, known as “epi-pens,” and the desire for an affordable alternative, CVS Health intends to market authorized generic version two-packs for $109.99 apiece. Read More »
A recent study has shown that using acetaminophen, an ingredient commonly found in painkillers, over a long period of time leads to an increased risk of hearing loss in adults. Read More »
Mylan CEO Heather Bresch presented at the 35th Annual J.P. Morgan Healthcare Conference in San Francisco. Read More »
The European Commission has granted Gilead Sciences Inc. marketing authorization for Vemlidy, a drug used in the treatment of people suffering from chronic Hepatitis B infections. Read More »
The U.S. Food and Drug Administration recently approved a license application for Mylan Biotechnology, in collaboration with Biocon, for the use of biosimilar tratuzumab in the treatment of breast cancer. Read More »
Gilead Sciences Inc., has awarded more than $22 million in grants to help fund HIV cure programs. Read More »
The Centers for Medicare and Medicaid Services hit a snag last week in seeking approval of a proposal that requires hospitals to have antimicrobial stewardship programs participating in Medicare and Medicaid programs. Read More »
Results from a November study have raised concerns about how pharmacists substitute generic medications for their name brand counterparts. Read More »
A new trend in communications is on the verge of creating a health care revolution, according to one rehabilitation clinic spokesperson. Read More »
The Centers for Disease Control and Prevention have released new resources to encourage pharmacists to take a more active role in the management of hypertension among their patients. Read More »
Ovarian cancer patients who have a sensitivity to chemotherapy will soon have another option to treat their disease as the U.S. Food and Drug Administration has approved Avastin as an alternative to or supplement for chemotherapy. Read More »
Alerts Sign-up
